Alsuhebany, N., Alkhalaf, H., Alshehri, F., Alkhulaifi, A., Almoteb, M., Alshammari, A., Alnuhait, M., Alfehaid, L., Alrajhi, A. M., Alzahrani, M., AlDoughaim, M. (2025). Validation of the HFA-ICOS cardiovascular toxicity risk tool in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors: Real-world data from the Saudi population.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e24009